Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CAPI 3 HEMOGLOBIN(E)

K-Number: K180762 · 2018-12-14

ApplicantSebia
Decision Date2018-12-14
Product CodeGKA
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

CAPI 3 HEMOGLOBIN(E) is a medical device manufactured by Sebia. It received FDA 510(k) clearance on 2018-12-14 under approval number K180762. The device is classified under product code GKA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CAPI 3 HEMOGLOBIN(E)?

CAPI 3 HEMOGLOBIN(E) is a medical device that received FDA 510(k) clearance on 2018-12-14. It is manufactured by Sebia. The 510(k) number is K180762.

When was CAPI 3 HEMOGLOBIN(E) approved by the FDA?

CAPI 3 HEMOGLOBIN(E) received FDA 510(k) clearance on 2018-12-14, under approval number K180762.

What company makes CAPI 3 HEMOGLOBIN(E)?

CAPI 3 HEMOGLOBIN(E) is manufactured by Sebia.

What is the FDA product code for CAPI 3 HEMOGLOBIN(E)?

The FDA product code for CAPI 3 HEMOGLOBIN(E) is GKA.

Other Devices by Sebia

View all 12 devices →

Related Devices (Code: GKA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.